C1-Esterase Inhibitor in Uncomplicated Pregnancy and Mild and Moderate Preeclampsia

Summary Routine coagulation tests and measurement of the plasma levels of C1-esterase inhibitor (C1-INH) and antithrombin III were performed in 17 women with mild preeclampsia, 10 women with moderate preeclampsia and 20 women with uncomplicated pregnancy. All pregnant probands were within the third trimester of pregnancy. 20 non-pregnant women were used as controls. The gfoups were matched in age and the pregnant ones were also matched in gestational age. C1-INH activity and antigen were significantly reduced (p <0.002) in normally pregnant women as compared with nonpregnant ones. Further, CI-INH activity was lower in women with mild preeclampsia and significantly lower in women with moderate preeclampsia (p <0.05) as compared with normally pregnant women. None of the plasmatic coagulation tests was indicative of a consumption reaction. We conclude that C1-INH activity and antigen reductions are commonly associated with pregnancy. Furthermore, as markedly lower values can be found in mild and moderate preeclampsia, measurement of the C1-INH activity in pregnant women within the third trimester might proof useful to establish the diagnosis of a preeclamptic condition.

[1]  A. Falus,et al.  Hormonal regulation of complement biosynthesis in human cell lines--I. Androgens and gamma-interferon stimulate the biosynthesis and gene expression of C1 inhibitor in human cell lines U937 and HepG2. , 1990, Molecular immunology.

[2]  G. Remuzzi,et al.  Effect of low‐dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy‐induced hypertension , 1990, The New England journal of medicine.

[3]  E. Frigas Angioedema with acquired deficiency of the C1 inhibitor: a constellation of syndromes. , 1989, Mayo Clinic proceedings.

[4]  E. Ruppin,et al.  The use of aspirin to prevent pregnancy‐induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies , 1989, The New England journal of medicine.

[5]  C. Greenberg,et al.  Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia. , 1989, Obstetrics and gynecology.

[6]  C. Hack,et al.  Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. , 1988, Blood.

[7]  F. Vivanco,et al.  Acquired C1-inhibitor deficiency associated with a lupus-like anticoagulant activity. , 1988, Annals of allergy.

[8]  C. Feighery,et al.  Autoantibody-mediated acquired deficiency of C1 inhibitor. , 1988, The New England journal of medicine.

[9]  R. Thorpe,et al.  Monoclonal antibodies to crosslinked fibrin degradation products (XL‐FDP) II. EVALUATION IN A VARIETY OF CLINICAL CONDITIONS , 1988, British journal of haematology.

[10]  J. Widmann,et al.  Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia. , 1987, The American journal of medicine.

[11]  J. Gilabert,et al.  Fibrinolysis in pre-eclampsia , 1987 .

[12]  H. Schwarz,et al.  PROTEIN C AND PROTEIN S IN MILD AND MODERATE PREECLAMPSIA , 1987, Thrombosis and Haemostasis.

[13]  A. Schmaier,et al.  Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor. , 1987, Archives of biochemistry and biophysics.

[14]  J. Alsenz,et al.  Autoantibody-mediated acquired deficiency of C1 inhibitor. , 1987, The New England journal of medicine.

[15]  B. Lämmle,et al.  Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen. , 1987, Seminars in thrombosis and hemostasis.

[16]  T. Terao,et al.  Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers. , 1987, Gynecologic and obstetric investigation.

[17]  F. Hentges,et al.  Acquired C1 esterase-inhibitor deficiency: case report with emphasis on complement and kallikrein activation during two patterns of clinical manifestations. , 1986, The Journal of allergy and clinical immunology.

[18]  C. Feighery,et al.  An IgG autoantibody which inactivates C1¯-inhibitor , 1986, Nature.

[19]  J. Grudzinskas,et al.  Complement activation, circulating protease inhibitors and pregnancy‐associated proteins in severe preeclampsia , 1986, British journal of obstetrics and gynaecology.

[20]  D. Chou Textbook of Clinical Chemistry , 1986 .

[21]  J. Gilabert,et al.  Fibrinolytic Activity and Protein C in Preeclampsia , 1986, Thrombosis and Haemostasis.

[22]  J. Westergaard,et al.  Quantitative Comparison of Circulating Immune Complexes in Normal Pregnancy and Pregnancy Related Hypertension , 1986, Acta obstetricia et gynecologica Scandinavica.

[23]  J. Jespersen,et al.  Increased Euglobulin Fibrinolytic Potential in Women on Oral Contraceptives Low in Oestrogen – Levels of Extrinsic and Intrinsic Plasminogen Activators, Prekallikrein, Factor XII, and C1-Inactivator , 1985, Thrombosis and Haemostasis.

[24]  G. Camussi,et al.  Immune complexes in preeclampsia and normal pregnancy. , 1985, American journal of obstetrics and gynecology.

[25]  F. Rosen,et al.  Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies. , 1985, The Journal of clinical investigation.

[26]  T. Meade,et al.  Haemostasis in Normal Pregnancy , 1984, Thrombosis and Haemostasis.

[27]  J. T. ten Cate,et al.  Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. , 1984, American journal of obstetrics and gynecology.

[28]  J. Weitz,et al.  Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia. , 1984, Blood.

[29]  J. Hustin,et al.  Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence. , 1985, Placenta.

[30]  D. Ogston,et al.  Blood levels of proteinase inhibitors in pre‐eclampsia , 1983, British journal of obstetrics and gynaecology.

[31]  H. Schuurman,et al.  IMMUNE COMPLEXES IN SKIN OF PATIENTS WITH PRE-ECLAMPTIC TOXAEMIA , 1982, The Lancet.

[32]  J. Stuart,et al.  Haemostatic and rheological changes in normal pregnancy and pre‐eclampsia , 1982, British journal of haematology.

[33]  M. Schalekamp,et al.  Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin. , 1982, The Journal of clinical endocrinology and metabolism.

[34]  J. Balasch,et al.  Further Evidence Against Preeclampsia as an Immune Complex Disease , 1981, Obstetrics and gynecology.

[35]  M. Blombäck,et al.  Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. , 1981, Gynecologic and obstetric investigation.

[36]  O. Ratnoff,et al.  Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. , 1980, The Journal of laboratory and clinical medicine.

[37]  G. Boss,et al.  Acquired C1 Esterase Inhibitor Deficiency and Angioedema: A Review , 1979, Medicine.

[38]  S. Holm A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[39]  R. Levinsky,et al.  IMMUNE COMPLEXES IN PREGNANCY , 1978, The Lancet.

[40]  J. Fink,et al.  Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. Acquired angioedema treated with danazol. , 1978, The Journal of allergy and clinical immunology.

[41]  J. Volanakis,et al.  A search for antigen-antibody complexes in pre-eclampsia: further evidence against immunologic pathogenesis. , 1978, American journal of obstetrics and gynecology.

[42]  P. Harber,et al.  Activation of the kallikrein-kinin system in Rocky Mountain spotted fever. , 1978, Annals of internal medicine.

[43]  R. Colman,et al.  Plasma kallikrein activation and inhibition during typhoid fever. , 1978, The Journal of clinical investigation.

[44]  R. Colman,et al.  Effect of Clofibrate on Intravascular Coagulation in Hyperlipoproteinemia , 1977, Circulation.

[45]  D. Ogston,et al.  SEQUENTIAL STUDIES ON COMPONENTS OF THE HAEMOSTATIC MECHANISM IN PREGNANCY WITH PARTICULAR REFERENCE TO THE DEVELOPMENT OF PRE‐ECLAMPSIA , 1976, British journal of obstetrics and gynaecology.

[46]  R. Colman,et al.  Kinin activation in the blood of patients with sepsis. , 1976, Surgery, gynecology & obstetrics.

[47]  F. Arias,et al.  Hepatic fibrinogen deposits in pre-eclampsia. Immunofluorescent evidence. , 1976, The New England journal of medicine.

[48]  R. Kallen,et al.  A Study of the Plasma Kinin-generating System in Children with the Minimal Lesion, Idiopathic Nephrotic Syndrome , 1975, Pediatric Research.

[49]  W. D. Creighton,et al.  Immunological studies of the human placenta. Characterization of immunoglobulins on trophoblastic basement membranes. , 1974, The Journal of clinical investigation.

[50]  R. Colman,et al.  Kallikrein-kinin system in postgastrectomy dumping syndrome. , 1974, Annals of internal medicine.

[51]  R. Colman,et al.  Activation of Hageman factor in the nephrotic syndrome. , 1974, The American journal of medicine.

[52]  J. Lawrence,et al.  Immunofluorescent Studies in Renal Biopsies in Pre-eclampsia , 1974, British medical journal.

[53]  K.,et al.  Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. , 1973, The Journal of clinical investigation.

[54]  Mason Jw,et al.  The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease. , 1971 .

[55]  C. Forbes,et al.  Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. , 1970, The Journal of laboratory and clinical medicine.

[56]  R. Colman,et al.  Plasma kallikrein and Hageman factor in Gram-negative bacteremia. , 1970, Annals of internal medicine.

[57]  G. P. Lewis Kinins in Inflammation and Tissue Injury , 1970 .

[58]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.